Literature DB >> 22076674

Pathophysiology of medication-overuse headache: implications from animal studies.

Saknan Bongsebandhu-phubhakdi1, Anan Srikiatkhachorn.   

Abstract

Recent animal experiments have shown that chronic medication exposure profoundly affects the function of several areas in the nervous system related to headache pathogenesis. These changes include upregulation of calcitonin gene-related peptide, substance P, and nitric oxide synthase in trigeminal ganglia; expansion of receptive field and decreased nociceptive threshold of central trigeminal neurons; decrease in diffuse noxious inhibitory control; and increased susceptibility to develop cortical spreading depression (CSD). These changes indicate an increase in excitability of cortical and trigeminal neurons. The neuronal hyperexcitability may be the result of derangement of a central, possibly serotonin (5-HT)-dependent, modulating control system. Experiments with animals with low 5-HT showed that the processes of CSD and trigeminal nociception are enhanced in this condition. Derangement in the central 5-HT-dependent modulating system as a result of chronic medication use may underlie the chronification of headache as observed in patients with medication-overuse headache.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22076674     DOI: 10.1007/s11916-011-0234-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  28 in total

1.  Reduced threshold for cortical spreading depression in female mice.

Authors:  Kevin C Brennan; Marcela Romero Reyes; Héctor E López Valdés; Arthur P Arnold; Andrew C Charles
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

2.  Platelet serotonin in patients with analgesic-induced headache.

Authors:  A Srikiatkhachorn; M Anthony
Journal:  Cephalalgia       Date:  1996-10       Impact factor: 6.292

3.  2002 Wolff Award. 5 -HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks.

Authors:  Anan Srikiatkhachorn; Chalalai Suwattanasophon; Unchalee Ruangpattanatawee; Pansiri Phansuwan-Pujito
Journal:  Headache       Date:  2002 Jul-Aug       Impact factor: 5.887

4.  Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.

Authors:  Chelsea A Meskunas; Stewart J Tepper; Alan M Rapoport; Fred D Sheftell; Marcelo E Bigal
Journal:  Headache       Date:  2006-05       Impact factor: 5.887

5.  Serotonin depletion leads to cortical hyperexcitability and trigeminal nociceptive facilitation via the nitric oxide pathway.

Authors:  Supang Maneesri le Grand; Weera Supornsilpchai; Chonlawan Saengjaroentham; Anan Srikiatkhachorn
Journal:  Headache       Date:  2011-06-07       Impact factor: 5.887

6.  Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers.

Authors:  P D Drummond
Journal:  Cephalalgia       Date:  2006-10       Impact factor: 6.292

7.  Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache.

Authors:  A Srikiatkhachorn; N Tarasub; P Govitrapong
Journal:  Headache       Date:  2000-05       Impact factor: 5.887

8.  Suppression of cortical spreading depression in migraine prophylaxis.

Authors:  Cenk Ayata; Hongwei Jin; Chiho Kudo; Turgay Dalkara; Michael A Moskowitz
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

9.  Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.

Authors:  Luis R Gardell; Ruizhong Wang; Shannon E Burgess; Michael H Ossipov; Todd W Vanderah; T Philip Malan; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache.

Authors:  Weera Supornsilpchai; Supang M le Grand; Anan Srikiatkhachorn
Journal:  Headache       Date:  2009-12-21       Impact factor: 5.887

View more
  6 in total

Review 1.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

2.  Drug-dependence behaviour and outcome of medication-overuse headache after treatment.

Authors:  Ilenia Corbelli; Stefano Caproni; Paolo Eusebi; Paola Sarchielli
Journal:  J Headache Pain       Date:  2012-10-18       Impact factor: 7.277

3.  Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex.

Authors:  Franz Riederer; Andreas R Gantenbein; Marvin Marti; Roger Luechinger; Spyridon Kollias; Peter S Sándor
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

Review 4.  Medication-overuse headache: a review.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  J Pain Res       Date:  2014-06-26       Impact factor: 3.133

5.  Volumetric abnormalities of thalamic subnuclei in medication-overuse headache.

Authors:  Zhiye Chen; Zhihua Jia; Xiaoyan Chen; Mengqi Liu; Shuangfeng Liu; Lin Ma; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-08-14       Impact factor: 7.277

Review 6.  Medication-overuse headache: a widely recognized entity amidst ongoing debate.

Authors:  Nicolas Vandenbussche; Domenico Laterza; Marco Lisicki; Joseph Lloyd; Chiara Lupi; Hannes Tischler; Kati Toom; Fenne Vandervorst; Simone Quintana; Koen Paemeleire; Zaza Katsarava
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.